A selective estrogen receptor modulator inhibits tumor necrosis factor-α-induced apoptosis through the ERK1/2 signaling pathway in human chondrocytes. [electronic resource]
Producer: 20120803Description: 418-24 p. digitalISSN:- 1090-2104
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Survival
- Chondrocytes -- drug effects
- Enzyme Activation
- Humans
- MAP Kinase Kinase 4 -- biosynthesis
- MAP Kinase Signaling System
- Mitogen-Activated Protein Kinase 1 -- biosynthesis
- Mitogen-Activated Protein Kinase 3 -- biosynthesis
- Proto-Oncogene Proteins c-akt -- biosynthesis
- RNA, Small Interfering -- genetics
- Raloxifene Hydrochloride -- pharmacology
- Selective Estrogen Receptor Modulators -- pharmacology
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- p38 Mitogen-Activated Protein Kinases -- biosynthesis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.